Gambro's medical equipment sales rise 9%
This article was originally published in Clinica
Swedish Gambro group's medical equipment sales rose 9% to SKr 4,493 million ($632 million) in the first six months of 1995 after adjustment for exchange rate effects and divestments. The strongest gains over corresponding 1994 figures were shown by blood component technology and renal care divisions - 17% and 9%, respectively.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.